Literature DB >> 17146151

AT1 receptor blockade prevents microvascular dysfunction induced by ischemia/reperfusion injury.

Kumiko Akiyoshi1, Tadafumi Akimitsu, Masahide Hara, Tetsunori Saikawa, Hironobu Yoshimatsu.   

Abstract

Ischemia/reperfusion (I/R) in post-arterior post-capillary venules induces an acute inflammatory response, characterized by increased adherence and emigration of leukocytes and vascular permeability, all of which play important roles in cardiovascular disease. The aim of this study was to determine the roles of angiotensin II and AT1 receptor blockade in microvascular I/R injury in rats. Rats were anesthetized and intubated, then the peritoneum was opened and the mesentery was revealed. Small post-capillary venules were examined by in vivo fluorescence microscopy. The flow of erythrocytes and leukocytes was observed under the microscope and video recorded for later dynamic analyses. The superior mesenteric artery (SMA) was ligated with polyethylene tubing and released to induce I/R (20 min of ischemia/60 min of reperfusion). Subsequently, leukocyte adhesion, emigration and albumin leakage were compared with those of non-I/R controls. I/R injury was significantly suppressed by superfusing tissues with the AT1 receptor antagonist losartan (LO; 10 microM). The beneficial effects of LO were inhibited by topical application of either the bradykinin B2 receptor antagonist HOE140 (10 nM) or nitric oxide (NO) synthase inhibitor Nomega-nitro-L-arginine methyl ester (L-NAME 10 microM). The effects of LO were lost in the presence of AT2 receptor blocker PD 123319 (PD). In conclusion, LO suppressed and protected against I/R injuries. The possible interaction between AT1 and AT2 receptors was also suggested.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17146151     DOI: 10.5551/jat.13.231

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  2 in total

1.  A novel role for calpain in the endothelial dysfunction induced by activation of angiotensin II type 1 receptor signaling.

Authors:  Rosario Scalia; Yulan Gong; Brett Berzins; Brin Freund; Danielle Feather; Gavin Landesberg; Gourav Mishra
Journal:  Circ Res       Date:  2011-03-17       Impact factor: 17.367

2.  Telmisartan protects against microvascular dysfunction during myocardial ischemia/reperfusion injury by activation of peroxisome proliferator-activated receptor γ.

Authors:  Xiao-Cong Zeng; Xing-San Li; Hong Wen
Journal:  BMC Cardiovasc Disord       Date:  2013-06-05       Impact factor: 2.298

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.